Arjun Agarwal serves as SVP, Finance at Oruka Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Arjun Agarwal has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 23, 2026 involved receiving (via award) 70,000 shares valued at $0.
Arjun Agarwal currently holds 70,000 shares of Oruka Therapeutics, Inc. (ORKA), valued at approximately $0. This represents their equity stake as SVP, Finance.
Based on SEC Form 4 filings, Arjun Agarwal has been a net neutral trader of ORKA stock. They have purchased $0 and sold $0 worth of shares.
Arjun Agarwal's most recent insider trade was on Jan 23, 2026, when they sold 70,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |